Skip to content
OpenCapital
Get started

Artivion AORT UNITED STATES — Perclot revenues

Similar metrics at other companies

Edwards Lifesciences logo
EWUnited States — Net Sales
$937.6M+11.8%
Krystal Biotech, Inc. logo
KRYSUnited States — Product revenue, net
$87.49M-0.8%
Enovis logo
ENOVUnited States — Net Sales
$323.83M+4.0%
Aurinia Pharmaceuticals logo
AUPHU.S. — Revenue
$65.96M+25.6%
NovoCure logo
NVCRUnited States — Net revenues
$95.96M+3.0%
Avanos Medical logo
AVNSUnited States — Net Sales
$130.8M-1.1%

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-24.8%
Enterprise value$1.27B-27.2%
P/E91.5×—
P/S2.3×-1.3×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Artivion’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's united states — perclot revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's UNITED STATES — perclot revenues?
Artivion (AORT) reported UNITED STATES — perclot revenues of $53.52M in Q4 2025.
How has Artivion's UNITED STATES — perclot revenues changed year-over-year?
Artivion's UNITED STATES — perclot revenues increased by 12.7% year-over-year, from $47.5M to $53.52M.
What is the long-term trend for Artivion's UNITED STATES — perclot revenues?
Over 4 years (2021 to 2025), Artivion's UNITED STATES — perclot revenues has grown at a 9.1% compound annual growth rate (CAGR), from $151.15M to $214.08M.
What does UNITED STATES — perclot revenues mean?
This metric represents the total net sales generated from the sale of hemostatic products within the United States geographic segment. It serves as a key indicator of market adoption and commercial performance for the company's specialized surgical adhesive portfolio in the domestic market.